TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome primary and acquired resistance to cancer immunotherapy, two ...

Barclays has recently initiated Tencent Music Entertainment Group – ADR (TME) stock to Overweight rating, as announced on November 6, 2024, according to Finviz. Earlier, on November 4, 2024, Bernstein ...

The Radiation Research Centre of Excellence (RadNet-CoE) at The Institute of Cancer Research and The Royal Marsden brings together preeminent leaders in radiotherapy, immunotherapy, cancer biology, ...

Coventry City match night blog from CoventryLive as Sky Blues reporter Andy Turner brings you updates of all the action from ...

Asian equities traded in the US as American depositary receipts were up modestly Wednesday morning, rising 0.11% to 2,097.77 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by ...

Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally.

Incendia Therapeutics today announced the appointment of Louis G. Lange, M.D., Ph.D., to the company’s Board of Directors, ...

DOVER, Del. and EPALINGES, Switzerland, Dec. 11, 2024 /PRNewswire/ -- Pilatus Biosciences Inc. announced that the U.S. Food ...

Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally ...

Charles Schwab Investment Management Inc. lifted its position in Tencent Music Entertainment Group (NYSE:TME – Free Report) by 15.1% during the 3rd quarter, according to the company in its most recent ...

The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release syndrome at ...

A study in mice offers evidence that inhibiting EZH2 can enhance lymphoma immunogenicity and overcome CAR-T cell therapy resistance.